StatPearls, LLC

  • Bernard-Soulier Syndrome
  • Bleeding Time

Bernard-Soulier Syndrome

Bernard-Soulier syndrome is a rare inherited blood clotting disorder characterized by unusually large, giant platelet cells, thrombocytopenia, and prolonged bleeding time. Due to the rarity of the disease, it may not appear foremost on the clinician’s differential. Affected individuals tend to bleed excessively and incur spontaneous ecchymoses. General coagulation studies may not be helpful, and the paucity of data may obscure the diagnosis. Acumen, supplemented by suspicion, may be the only way to approach this disorder. The disease is familial, and the diagnosis of one patient, the proband, necessitates the consideration of family members as well. This activity reviews the evaluation and treatment of Bernard-Soulier syndrome and highlights the role of the interprofessional healthcare team in evaluating and managing patients with this condition. Clinicians participating in this activity will gain an understanding of the defect in the GPIb-IX-V complex, a critical platelet receptor complex with multifaceted roles in von Willebrand factor binding, thrombosis, and hemostasis. By delving into the intricacies of this rare blood clotting disorder, healthcare professionals will enhance their acumen and suspicion skills, crucial for accurate identification and subsequent multidisciplinary treatment.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left